Evidence map›Paper›PMID 33790127›Full record

ArticleJournal of atherosclerosis and thrombosis2022

Trends, Treatment Approaches, and In-Hospital Mortality for Acute Coronary Syndrome in Japan During the Coronavirus Disease 2019 Pandemic.

Tetsuji Morishita, Daisuke Takada, Jung-Ho Shin, Takuya Higuchi, Susumu Kunisawa, Yuichi Imanaka

Open access · diamondAbstract read
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tetsuji MorishitaDepartment of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University.
Daisuke TakadaDepartment of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University.
Jung-Ho ShinDepartment of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University.
Takuya HiguchiDepartment of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University.
Susumu KunisawaDepartment of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University.
Yuichi ImanakaDepartment of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe coronavirus disease 2019 (COVID-19) pandemic has left negative spillover effects on the entire health care system. Previous studies have suggested significant declines in cases of acute coronary syndrome (ACS) and primary percutaneous coronary intervention (PCI) during the COVID-19 pandemic.

methodsWe performed a quasi-experimental, retrospective cohort study of ACS hospitalisations by using a multi-institutional administrative claims database in Japan. We used interrupted time series analyses to ascertain impacts on cases, treatment approaches, and in-hospital mortality before and after Japan's state of emergency to respond to COVID-19. The primary outcome was the change in ACS cases per week.

resultsA total of 30,198 ACS cases (including 21,612 acute myocardial infarction and 8,586 unstable angina) were confirmed between 1

conclusionsWe demonstrated the characteristics and trends of ACS cases in a Japanese population by applying interrupted time series analyses. Our findings provide significant insights into the association between COVID-19 and decreases in ACS hospitalisations during the pandemic.

Indexed as

Acute Coronary SyndromeCOVID-19Percutaneous Coronary InterventionHospital MortalityHumansJapanPandemicsRetrospective StudiesAcute coronary syndromeAcute myocardial infarctionCoronavirus disease 2019Fibrinolytic therapyIn-hospital mortalityPrimary percutaneous coronary interventionUnstable angina

Identifiers

PMID33790127
PMCPMC9135656
OpenAlexW3143420626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.